Pharm
Advanced Generation Cephalosporin
search
Advanced Generation Cephalosporin
, Fourth Generation Cephalosporin, Fifth Generation Cephalosporin
See Also
Cephalosporin
Background
The fourth and Fifth Generation Cephalosporins are loosely grouped newer agents
Contrast with the first to
Third Generation Cephalosporin
s that formed discrete groups with similar antimicrobial activity
Medications
Fourth
Gene
ration
Cefepime
(
Maxipime
)
Broad spectrum Gram-positive and Gram-negative organisms (building on
Third Generation Cephalosporin
coverage)
Beta-Lactamase
resistant organisms
More AmpB
Beta Lactam
ase resistant than second and
Third Generation Cephalosporin
s
Better activity against
Citrobacter
and
Enterobacter
Pseudomonas
coverage (similar to
Ceftazidime
)
Although some anaerobic coverage, not active against
Bacteroides fragilis
Use with
Metronidazole
for intraabdominal infections
Ceftolozane and Tazobactam
(
Zerbaxa
)
Gram-Negative Bacteria
(aerobes and
Anaerobe
s)
Multidrug Resistant
Enterobacteriaceae
(
Ceftazidime
-resistant, ESBL)
Bacteroides
Prevotella
Pseudomonas Aeruginosa
Medications
Fifth
Gene
ration
Ceftaroline
(
Teflaro
)
Multidrug-resistant
Staphylococcus Aureus
Methicillin
-resistant
Staphylococcus Aureus
(
MRSA
)
Vancomycin
-intermediate
Staphylococcus Aureus
(VISA) and heteroresistant VISA
Vancomycin
-Resistant
Staphylococcus Aureus
)
Streptococcus
Pneumonia
Includes drug-resistant strains
Respiratory
Gram-Negative Bacteria
(including
Beta-Lactamase
-positive
Bacteria
)
Moraxella catarrhalis
Haemophilus Influenzae
Cefiderocol
(
Fetroja
)
Gene
ral
Structurally similar to
Cefepime
and
Ceftazidime
Effective against multi-drug resistant
Gram Negative
aerobic
Bacteria
Indicated in complicated
Urinary Tract Infection
s including
Pyelonephritis
Does not provide adequate
Gram Positive
or anaerobic activity
Covers
Multidrug-Resistant Organism
s in complicated
Urinary Tract Infection
s
Escherichia coli
Enterobacter
cloacae complex
Klebsiella Pneumoniae
Proteus Mirabilis
Pseudomonas
Type your search phrase here